77 research outputs found
Le complexe GIT-PIX : Une plate-forme de régulation des GTPases ARF et Rac/Cdc42
Les protĂ©ines G sont des commutateurs molĂ©culaires contrĂŽlant divers aspects de la vie cellulaire tels que la transduction du signal, la rĂ©organisation du cytosquelette et les mĂ©canismes de transport vĂ©siculaire. Ces protĂ©ines fixent alternativement les nuclĂ©otides GDP et GTP, ce qui leur permet de transiter entre deux conformations structurelles, respectivement inactive et active. Lâactivation des protĂ©ines G rĂ©sulte dâune interaction avec un facteur dâĂ©change qui stimule la dissociation du GDP pour le remplacer par du GTP. Câest sous cette forme liĂ©e au GTP que les protĂ©ines G vont pouvoir interagir avec leurs effecteurs et les activer. La stimulation de lâactivitĂ© intrinsĂšque dâhydrolyse des protĂ©ines G par des protĂ©ines GAP (GTPase activating protein) va conduire Ă un retour vers la forme inactive liĂ©e au GDP. De nombreuses Ă©tudes ont montrĂ© lâexistence dâinterconnexions entre les voies de signalisation impliquant les GTPases ARF (ADP ribosylation factor) et Rac/Cdc42. La dĂ©couverte dâun complexe protĂ©ique comprenant PIX, un facteur dâĂ©change pour Rac/Cdc42 et GIT1, une protĂ©ine GAP pour les ARF, a rĂ©cemment donnĂ© un nouvel Ă©clairage sur les moyens mis en oeuvre par la cellule pour rĂ©guler de façon Ă©troite lâagencement du cytosquelette et la dynamique des membranes. De plus, la plate-forme PIX-GIT1 est associĂ©e Ă des rĂ©seaux de signalisation comprenant des suppresseurs de tumeur. Ces donnĂ©es rĂ©centes incitent Ă prendre ce complexe en considĂ©ration dans le contexte des pathologies cancĂ©reuses.We recently described that the tumor suppressor factor Scribble anchors the PIX exchange factor for Rac/Cdc42 and the ARF-GAP GIT proteins at the plasma membrane. Because it has been postulated that the GIT-PIX proteins dimerize and tightly self-assemble to form a high molecular weight complex, this nexus may be capable of linking together important signalling molecules to control cytosqueleton polymerization and membrane dynamics. To date, most studies that have tempted to unravel the function of these proteins have found their implication in a great variety of cellular functions (receptor recycling, endo-exocytosis, cell migration, synapse formationâŠ) but have mostly neglected to consider the multimeric organization of this hub. There is no doubt that our comprehension of physiopathological disorders such as cancers will be improved when the nature of the complex pathways integrated by the GIT-PIX nodule will be understood
Identification of caspase 3 motifs and critical aspartate residues in human Phospholipase D1b and Phopsholipase D2a
Stimulation of mammalian cells frequently initiates phospholipase D-catalysed
hydrolysis of phosphatidylcholine in the plasma membrane to yield phosphatidic acid
(PA) a novel lipid messenger. PA plays a regulatory role in important cellular
processes such as secretion, cellular shape change and movement. A number of
studies have highlighted that PLD-based signalling also plays a pro-mitogenic and
pro-survival role in cells and therefore anti-apoptotic. We show that human PLD1b
and PLD2a contain functional caspase-3 cleavage sites and identify the critical
aspartate residues within PLD1b that affect its activation by phorbol esters and
attenuate phosphatidylcholine hydrolysis during apoptosis
An unconventional diacylglycerol kinase that regulates phospholipid synthesis and nuclear membrane growth
Changes in nuclear size and shape during the cell cycle or during development require coordinated nuclear membrane remodeling, but the underlying molecular events are largely unknown. We have shown previously that the activity of the conserved phosphatidate phosphatase Pah1p/Smp2p regulates nuclear structure in yeast by controlling phospholipid synthesis and membrane biogenesis at the nuclear envelope. Two screens for novel regulators of phosphatidate led to the identification of DGK1. We show that Dgk1p is a unique diacylglycerol kinase that uses CTP, instead of ATP, to generate phosphatidate. DGK1 counteracts the activity of PAH1 at the nuclear envelope by controlling phosphatidate levels. Overexpression of DGK1 causes the appearance of phosphatidate-enriched membranes around the nucleus and leads to its expansion, without proliferating the cortical endoplasmic reticulum membrane. Mutations that decrease phosphatidate levels decrease nuclear membrane growth in pah1Î cells. We propose that phosphatidate metabolism is a critical factor determining nuclear structure by regulating nuclear membrane biogenesis
Signal integration by lipid-mediated spatial cross talk between Ras nanoclusters
Lipid-anchored Ras GTPases form transient, spatially segregated nanoclusters on the plasma membrane that are essential for high-fidelity signal transmission. The lipid composition of Ras nanoclusters however has not previously been investigated. High-resolution spatial mapping shows that different Ras nanoclusters have distinct lipid compositions indicating that Ras proteins engage in isoform-selective lipid sorting, and accounting for different signal outputs from each Ras isoform. Phosphatidylserine is a common constituent of all Ras nanoclusters but is only an obligate structural component of K-Ras nanoclusters. Segregation of K-Ras and H-Ras into spatially and compositionally distinct lipid assemblies is exquisitely sensitive to plasma membrane phosphatidylserine levels. Phosphatidylserine spatial organization is also modified by Ras nanocluster formation. In consequence Ras nanoclusters engage in remote lipid-mediated communication, whereby activated H-Ras disrupts the assembly and operation of spatially segregated K-Ras nanoclusters. Computational modeling and experiment reveal that complex effects of caveolin and cortical actin on Ras nanoclustering are similarly mediated through regulation of phosphatidylserine spatiotemporal dynamics. We conclude that phosphatidylserine maintains the lateral segregation of diverse lipid-based assemblies on the plasma membrane and that lateral connectivity between spatially remote lipid assemblies offers important, previously unexplored opportunities for signal integration and signal processing
5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail
The 5-HT2AR (5-hydroxytryptamine-2A receptor) is a GPCR (G-protein-coupled receptor) that is implicated in the actions of hallucinogens and represents a major target of atypical antipsychotic agents. In addition to its classical signalling though PLC (phospholipase C), the receptor can activate several other pathways, including ARF (ADP-ribosylation factor)-dependent activation of PLD (phospholipase D), which appears to be achieved through a mechanism independent of heterotrimeric G-proteins. In the present study we show that wild-type and inactive constructs of PLD1 (but not PLD2) respectively facilitate and inhibit ARF-dependent PLD signalling by the 5-HT2AR. Furthermore we demonstrate that PLD1 specifically co-immunoprecipitates with the receptor and binds to a distal site in GST (glutathione transferase) fusion protein constructs of its C-terminal tail which is distinct from the ARF-interaction site, thereby suggesting the existence of a functional ARF-PLD signalling complex directly associated with this receptor. This reveals the spatial co-ordination of an important GPCR, transducer and effector into a physical complex that is likely to reinforce the impact of receptor activation on a heterotrimeric G-protein-independent signalling pathway. Signalling of this receptor through such non-canonical pathways may be important to its role in particular disorders
Perturbed proteostasis in autism spectrum disorders
Dynamic changes in synaptic strength rely on de novo protein synthesis and protein degradation by the ubiquitin proteasome system (UPS). Disruption of either of these cellular processes will result in significant impairments in synaptic plasticity and memory formation. Mutations in several genes encoding regulators of mRNA translation and members of the UPS have been associated with an increased risk for the development of autism spectrum disorders. It is possible that these mutations result in a similar imbalance in protein homeostasis (proteostasis) at the synapse. This review will summarize recent work investigating the role of the UPS in synaptic plasticity at glutamatergic synapses, and propose that dysfunctional proteostasis is a common consequence of several genetic mutations linked to autism spectrum disorders. [Image: see text] Dynamic changes in synaptic strength rely on de novo protein synthesis and protein degradation by the ubiquitin proteasome system (UPS). Disruption of either of these cellular processes will result in significant impairments in synaptic plasticity and memory formation. Mutations in several genes encoding regulators of mRNA translation (i.e. FMR1) and protein degradation (i.e. UBE3A) have been associated with an increased risk for autism spectrum disorders and intellectual disability (ASD/ID). These mutations similarly disrupt protein homeostasis (proteostasis). Compensatory changes that reset the rate of proteostasis may contribute to the neurological symptoms of ASD/ID. This review summarizes recent work investigating the role of the UPS in synaptic plasticity at glutamatergic synapses, and proposes that dysfunctional proteostasis is a common consequence of several genetic mutations linked to ASD. This article is part of a mini review series: âSynaptic Function and Dysfunction in Brain Diseasesâ
Pseudoacromegaly
© 2018 Elsevier Inc. Individuals with acromegaloid physical appearance or tall stature may be referred to endocrinologists to exclude growth hormone (GH) excess. While some of these subjects could be healthy individuals with normal variants of growth or physical traits, others will have acromegaly or pituitary gigantism, which are, in general, straightforward diagnoses upon assessment of the GH/IGF-1 axis. However, some patients with physical features resembling acromegaly â usually affecting the face and extremities â, or gigantism â accelerated growth/tall stature â will have no abnormalities in the GH axis. This scenario is termed pseudoacromegaly, and its correct diagnosis can be challenging due to the rarity and variability of these conditions, as well as due to significant overlap in their characteristics. In this review we aim to provide a comprehensive overview of pseudoacromegaly conditions, highlighting their similarities and differences with acromegaly and pituitary gigantism, to aid physicians with the diagnosis of patients with pseudoacromegaly.PM is supported by a clinical fellowship by Barts and the London Charity. Our studies on pituitary adenomas and related conditions received support from the Medical Research Council, Rosetrees Trust and the Wellcome Trust
- âŠ